Effects of Olanzapine on Bone Mineral Density, Glucose, and Lipid Metabolism in Schizophrenia Patients

Table 6

HOMA-IR-based subgroup analysis of biochemical and BMD characteristics in the olanzapine-treated group ().

	IR ()	Non-IR ()
TG (mmol/L)			0.001
CHOL (mmol/L)			0.011
HDL (mmol/L)			0.125
LDL (mmol/L)			0.688
FBG (mmol/L)			<0.001
Insulin (μU/mL)			<0.001
BMD, radius+ulna (g/cm^2)
1/3			0.698
MID			0.787
UD			0.462
TOTAL			0.964
BMD, lumbar (g/cm^2)
L1			0.044
L2			0.144
L3			0.059
L4			0.180
L1-4			0.182
BMD, left hip (g/cm^2)
NECK			<0.001
TROCH			0.005
WARD			0.002
T-HIP			0.001